
Combination Therapies and Resistance-Based Approaches Reshape EGFR Care
In an interview with Pharmacy Times® at the HOPA 2025 Annual Meeting, Mya Tran, PharmD, BCOP, precision oncology–thoracic clinical oncology pharmacist from Indiana University Health Simon Cancer Center highlighted recent advancements in EGFR treatments, …